ATE267202T1 - 1,4-diazabicyclo(3.2.2)nonanbenzoxazol-, benzothiazol- und benzoimidazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung - Google Patents

1,4-diazabicyclo(3.2.2)nonanbenzoxazol-, benzothiazol- und benzoimidazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung

Info

Publication number: ATE267202T1
Authority: AT; Austria
Prior art keywords: nonanbenzoxazole; benzothiazole; diazabicyclo; production; therapeutic use
Prior art date: 2000-05-31

Application number

AT01938363T

Other languages

English (en)

Inventor

Frederic Galli

Alistair Lochead

Axelle Samson

Original Assignee

Sanofi Synthelabo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-31

Filing date

2001-05-29

Publication date

2004-06-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8850826&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE267202(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-05-29 Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo

2004-06-15 Application granted granted Critical

2004-06-15 Publication of ATE267202T1 publication Critical patent/ATE267202T1/de

Links

IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 title 2
FTTATHOUSOIFOQ-UHFFFAOYSA-N 1,2,3,4,6,7,8,8a-octahydropyrrolo[1,2-a]pyrazine Chemical compound C1NCCN2CCCC21 FTTATHOUSOIFOQ-UHFFFAOYSA-N 0.000 title 1
HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical class C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT01938363T 2000-05-31 2001-05-29 1,4-diazabicyclo(3.2.2)nonanbenzoxazol-, benzothiazol- und benzoimidazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung ATE267202T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0006975A FR2809730B1 (fr)	2000-05-31	2000-05-31	Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique
PCT/FR2001/001651 WO2001092261A1 (fr)	2000-05-31	2001-05-29	Derives de 1,4-diazabicyclo [3.2.2]nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique

Publications (1)

Publication Number	Publication Date
ATE267202T1 true ATE267202T1 (de)	2004-06-15

Family

ID=8850826

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01938363T ATE267202T1 (de)	2000-05-31	2001-05-29	1,4-diazabicyclo(3.2.2)nonanbenzoxazol-, benzothiazol- und benzoimidazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung

Country Status (11)

Country	Link
US (1)	US7220740B2 (de)
EP (1)	EP1289988B1 (de)
JP (1)	JP4939721B2 (de)
AR (1)	AR028647A1 (de)
AT (1)	ATE267202T1 (de)
AU (1)	AU2001264044A1 (de)
DE (1)	DE60103395T2 (de)
FR (1)	FR2809730B1 (de)
HU (1)	HU229102B1 (de)
TW (1)	TW541307B (de)
WO (1)	WO2001092261A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0000540D0 (sv)	2000-02-18	2000-02-18	Astrazeneca Ab	New compounds
US20020086871A1 (en) *	2000-12-29	2002-07-04	O'neill Brian Thomas	Pharmaceutical composition for the treatment of CNS and other disorders
CA2448913A1 (en) *	2001-07-06	2003-01-16	Neurosearch A/S	Sulfone containing bicyclic aromatic ring compounds, their preparation and use as nicotinic acetyl-chloine receptors
FR2832714B1 (fr)	2001-11-23	2004-07-16	Sanofi Synthelabo	Derives de 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique
SE0202465D0 (sv) *	2002-08-14	2002-08-14	Astrazeneca Ab	New compounds
US7456171B2 (en)	2002-10-08	2008-11-25	Sanofi-Aventis	1,4-Diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof
FR2845388B1 (fr) *	2002-10-08	2004-11-12	Sanofi Synthelabo	Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique
EP1562945B1 (de) *	2002-11-11	2006-11-15	Neurosearch A/S	1,4-dizabicyclo(3,2,2)nonane derivative, verfahren zur ihre herstellung und therapeutical verwendung
US7223753B2 (en)	2002-11-11	2007-05-29	Neurosearch A/S	Diazabicyclic biaryl derivatives
EP1599476B1 (de) *	2003-02-27	2009-10-14	Neurosearch A/S	Neue diazabicyclische arylderivate
FR2865208B1 (fr) *	2004-01-16	2009-01-16	Sanofi Synthelabo	Derives de 1,4-diazabicyclo[3.2.1]octanecarboxmique, leur preparation et leur application en therapeutique
EP1713487B1 (de) *	2004-02-04	2009-12-02	Neurosearch A/S	Diazabicyclische aryl-derivate als cholinerge rezeptor-modulatoren
WO2006051413A1 (en) *	2004-11-15	2006-05-18	Pfizer Inc.	Azabenoxazoles for the treatment of cns disorders
WO2006051410A1 (en) *	2004-11-15	2006-05-18	Pfizer Inc.	Azabenzoxazoles for the treatment of cns disorders
WO2006051407A1 (en) *	2004-11-15	2006-05-18	Pfizer Products Inc.	Azabenzoxazoles for the treatment of cns disorders
DE602006019561D1 (de)	2005-02-16	2011-02-24	Neurosearch As	Diazabicyclische arylderivate und ihre verwendung als chinolinergische liganden an nikotin-acetylcholin-rezeptoren
EP2029607A1 (de)	2006-05-23	2009-03-04	NeuroSearch A/S	Neuartige 8,10-diaza-bicyclo[4.3.1]decan-derivate und ihre medizinische verwendung
CN104262348B (zh) *	2014-08-15	2017-12-15	北京师范大学	一种α7烟碱型乙酰胆碱受体配体及其制备方法
CN107188900B (zh) *	2017-05-27	2019-09-06	北京师范大学	α7烟碱型乙酰胆碱受体的配体化合物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IN166416B (de) *	1985-09-18	1990-05-05	Pfizer
NZ226000A (en) *	1987-09-10	1991-06-25	Merck Sharp & Dohme	Oxadiazolyl-azabicycloheptanes and pharmaceutical compositions
US5478939A (en) *	1994-07-20	1995-12-26	American Cyanamid Company	(R,R) and (S,S) 2,5-diazabicyclo [2,2,1]heptane derivatives
FR2786770B1 (fr)	1998-12-04	2001-01-19	Synthelabo	Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
US20020086871A1 (en) *	2000-12-29	2002-07-04	O'neill Brian Thomas	Pharmaceutical composition for the treatment of CNS and other disorders

2000
- 2000-05-31 FR FR0006975A patent/FR2809730B1/fr not_active Expired - Fee Related
2001
- 2001-05-29 JP JP2002500874A patent/JP4939721B2/ja not_active Expired - Fee Related
- 2001-05-29 HU HU0302193A patent/HU229102B1/hu not_active IP Right Cessation
- 2001-05-29 WO PCT/FR2001/001651 patent/WO2001092261A1/fr not_active Ceased
- 2001-05-29 US US10/276,646 patent/US7220740B2/en not_active Expired - Lifetime
- 2001-05-29 AU AU2001264044A patent/AU2001264044A1/en not_active Abandoned
- 2001-05-29 EP EP01938363A patent/EP1289988B1/de not_active Expired - Lifetime
- 2001-05-29 DE DE60103395T patent/DE60103395T2/de not_active Expired - Lifetime
- 2001-05-29 AT AT01938363T patent/ATE267202T1/de not_active IP Right Cessation
- 2001-05-30 TW TW090113060A patent/TW541307B/zh not_active IP Right Cessation
- 2001-05-30 AR ARP010102574A patent/AR028647A1/es active IP Right Grant

Also Published As

Publication number	Publication date
AR028647A1 (es)	2003-05-21
AU2001264044A1 (en)	2001-12-11
EP1289988A1 (de)	2003-03-12
WO2001092261A1 (fr)	2001-12-06
US20030153574A1 (en)	2003-08-14
FR2809730B1 (fr)	2002-07-19
JP4939721B2 (ja)	2012-05-30
HU229102B1 (en)	2013-07-29
FR2809730A1 (fr)	2001-12-07
DE60103395D1 (de)	2004-06-24
DE60103395T2 (de)	2005-06-16
TW541307B (en)	2003-07-11
US7220740B2 (en)	2007-05-22
JP2003535091A (ja)	2003-11-25
HUP0302193A2 (hu)	2003-11-28
EP1289988B1 (de)	2004-05-19
HUP0302193A3 (en)	2012-02-28

Legal Events

Date	Code	Title	Description
2004-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE347890T1 (de)	2007-01-15	Diarylcycloalkylderivate, verfahren zu ihrer herstellung und ihre verwendung als ppar- aktivatoren
DE60033028D1 (de)	2007-03-08	5-pyridyl-1,3-azol-derivate, verfahren zu ihrer herstellung und ihre verwendung
ATE294785T1 (de)	2005-05-15	2-aminothiazolederivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
DE60313602D1 (de)	2007-06-14	N-iPHENYL(PIPERIDIN-2-YL)METHYLöBENZAMIDDERIVATE,VERFAHREN ZU IHRER HERSTELLUNG UND IHRE THERAPEUTISCHE ANWENDUNG
ATE252578T1 (de)	2003-11-15	1,3-oxazolin- und 1,3-thiazolin-derivate, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel
DE60231548D1 (de)	2009-04-23	N; formkörper und verfahren zu ihrer herstellung
DE50011035D1 (de)	2005-09-29	Sulfonylcarboxamidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE10393704D2 (de)	2005-07-21	Nancomposite, Verfahren zu ihrer Herstellung und ihre Verwendung
DE60233058D1 (de)	2009-09-03	Silsesquioxanderivate und verfahren zu ihrer herstellung
DE50101931D1 (de)	2004-05-13	Substituierte sulfonylaminomethylbenzoesäure(derivate) und verfahren zu ihrer herstellung
ATE327981T1 (de)	2006-06-15	Arylisoxazolin-derivative, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel
DE60103395D1 (de)	2004-06-24	1,4-diazabicyclo[3.2.2]nonanbenzoxazol-, benzothiazol- und benzoimidazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
ATE272634T1 (de)	2004-08-15	Benzothiophenderivate, verhahren zu ihrer herstellung und ihre verwendung
DE60111904D1 (de)	2005-08-18	Biosensor und verfahren zu dessen herstellung
DE69812365D1 (de)	2003-04-24	Enthaarungsmitteln, verfahren zur herstellung sowie ihre verwendung
DE50011818D1 (de)	2006-01-12	Hochkratzfeste mehrschichtlackierung, verfahren zu ihrer herstellung und ihre verwendung
ATE210638T1 (de)	2001-12-15	Biphenylsulfonylcyanamide, verfahren zu ihrer herstellung und ihre verwendung als medikament
ATE283842T1 (de)	2004-12-15	Substituierte benzoylketone, verfahren zu ihrer herstellung und ihre verwendung als herbizide
DE60012288D1 (de)	2004-08-26	Antivirale pyrimidindion-derivate und verfahren zu ihrer herstellung
ATE302765T1 (de)	2005-09-15	2-arylimino-2,3-dihydrothiazol derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
DE69922378D1 (de)	2005-01-05	Oxidierte sulfurierte distamycinderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
ATE313556T1 (de)	2006-01-15	Memno-peptide, verfahren zu ihrer herstellung und ihre verwendung
DE59902408D1 (de)	2002-09-26	Biphenylsulfonylcyanamide, verfahren zu ihrer herstellung und ihre verwendung als medikament
ATE263755T1 (de)	2004-04-15	Neue antiestrogene, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
ATE288442T1 (de)	2005-02-15	Cyclipostine, verfahren zu ihrer herstellung und verwendung derselben